Financial Ratios

HEMO ORGANIC LTD.

NSE : NABSE : 524590ISIN CODE : INE422G01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE11.59-0.6 (-4.92 %)
PREV CLOSE ( ) 12.19
OPEN PRICE ( ) 11.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1789
TODAY'S LOW / HIGH ( )11.59 11.82
52 WK LOW / HIGH ( ) 5.5712.35
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.16-0.18-0.14-0.06-0.35
   CEPS(Rs)-0.16-0.18-0.14-0.06-0.35
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-0.150.010.190.330.39
   Tax Rate(%)0.000.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-1144.74-910.67-591.47-6.84-219.71
   EBIT Margin(%)-1144.74-910.67-591.47-6.84-219.71
   Pre Tax Margin(%)-1146.21-913.15-593.22-7.87-219.71
   PAT Margin (%)-1146.21-913.15-593.22-7.87-219.71
   Cash Profit Margin (%)-1146.21-913.15-593.22-7.87-219.71
Performance Ratios
   ROA(%)-36.17-65.16-47.99-4.75-14.38
   ROE(%)0.00-180.16-53.35-17.52-61.38
   ROCE(%)-486.91-89.29-44.09-11.35-43.09
   Asset Turnover(x)0.030.070.080.600.07
   Sales/Fixed Asset(x)1.422.032.3982.2516.21
   Working Capital/Sales(x)-0.03-0.07-0.19-10.310.72
Efficiency Ratios
   Fixed Capital/Sales(x)0.710.490.420.010.06
   Receivable days4527.913370.673067.58530.414876.84
   Inventory Days1229.60513.4683.432.2687.88
   Payable days0.003748.337287.47793.493607.95
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-45.01-285.08-105.70-184.200.00
   Price/Book(x)-48.025177.6576.9035.370.00
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)498.822607.01629.6914.4164.58
   EV/Core EBITDA(x)-43.58-286.27-106.46-210.59-29.39
   EV/EBIT(x)-43.58-286.27-106.46-210.59-29.39
   EV/CE(x)11.68180.6254.7337.464.35
   M Cap / Sales515.892603.23627.0414.500.00
Growth Ratio
   Net Sales Growth(%)-30.16-15.37-97.09407.47-37.12
   Core EBITDA Growth(%)12.21-30.31-151.6184.1918.89
   EBIT Growth(%)12.21-30.31-151.6184.1918.89
   PAT Growth(%)12.34-30.28-119.3481.8118.89
   EPS Growth(%)12.34-30.27-119.2181.8018.89
Financial Stability Ratios
   Total Debt/Equity(x)-0.6910.210.530.020.61
   Current Ratio(x)0.560.480.690.801.10
   Quick Ratio(x)0.520.400.670.791.10
   Interest Cover(x)-780.06-368.04-338.52-6.64
   Total Debt/Mcap(x)0.010.000.010.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.